| Stage | TSLA | % of rev | FSS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $28.0B | 100.00% | $656M | 100.00% | TSLA ×42.79 |
| Gross profit | $5.5B | 19.59% | $189M | 28.86% | FSS +9.3pp |
| Operating income | $718M | 2.56% | $111M | 16.99% | FSS +14.4pp |
| Pre-tax income | $956M | 3.41% | $105M | 16.03% | FSS +12.6pp |
| Net income | $804M | 2.87% | $80M | 12.14% | FSS +9.3pp |
| Stage | TSLA | FSS | Gap · A − B |
|---|---|---|---|
| Revenue | $28.0B100.00% | $656M100.00% | TSLA ×42.79 |
| Gross profit | 19.59%$5.5B | 28.86%$189M | FSS +9.3pp |
| Operating income | 2.56%$718M | 16.99%$111M | FSS +14.4pp |
| Pre-tax income | 3.41%$956M | 16.03%$105M | FSS +12.6pp |
| Net income |
| 2.87%$804M |
| 12.14%$80M |
| FSS +9.3pp |
No disclosed counterparties: FSS.
None